Clinical Trial Update: Trial to Determine the Immunomodulatory Activity of PTM-001 in Patients With Hidradenitis Suppurativa [Phase 2]

View source ↗

Summary

Phase 2 trial assessing immunomodulatory activity of PTM-001 in hidradenitis suppurativa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• PTM-001

Snippet

Sponsor: Phoenicis Therapeutics | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: UNKNOWN